Cue Biopharma, Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2022-11-14: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2022-08-04: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2022-05-10: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2022-03-16: Form 10-K; Item Emerging growth company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2022-11-14 | 10-Q | Emerging growth company | Yes |
| 2022-08-04 | 10-Q | Emerging growth company | Yes |
| 2022-05-10 | 10-Q | Emerging growth company | Yes |
| 2022-03-16 | 10-K | Emerging growth company | Yes |
| 2021-11-09 | 10-Q | Emerging growth company | Yes |
| 2021-08-09 | 10-Q | Emerging growth company | Yes |
| 2021-05-10 | 10-Q | Emerging growth company | Yes |
| 2021-03-09 | 10-K | Emerging growth company | Yes |
| 2020-11-09 | 10-Q | Emerging growth company | Yes |
| 2020-08-07 | 10-Q | Emerging growth company | Yes |
| 2020-05-07 | 10-Q | Emerging growth company | Yes |
| 2020-03-12 | 10-K | Emerging growth company | Yes |
| 2019-11-07 | 10-Q | Emerging growth company | Yes |
| 2019-08-08 | 10-Q | Emerging growth company | Yes |
| 2019-05-08 | 10-Q | Emerging growth company | Yes |
| 2019-03-14 | 10-K | Emerging growth company | Yes |
| 2018-11-13 | 10-Q | Smaller reporting company | No |
| 2018-11-13 | 10-Q | Emerging growth company | Yes |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |